Nova Lab`s Qaialdo (spironolactone) Receives Approval in Europe
For two decades Nova Laboratories has provided clinical trials medication to a global customer base of pharmaceutical and biotechnology companies, academic and charitable institutions and the UK’s NHS. In this time the company has developed extensive expertise in the use of high-integrity, gassed isolator technology, which has been acknowledged by various regulators as ‘Advanced Aseptic Technology’. This expertise in complex and novel aseptic processes, clinical manufacturing of parenterals and devices now provides the company’s main role and has allowed it to develop commercial manufacturing processes for specialist sterile products.
Nova Laboratories News Full Screen View
Market Place
Share